← Eichor
Study identifier: NCT07059000 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

Condition: Chronic Primary Immune Thrombocytopenia (ITP)  ·  Sponsor: Kedrion S.p.A.

PhasePhase 3
Planned participants40
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP

This description comes directly from the study's public registry record.

Talk to the study team

Anna Lotti Suffredini  ·  +39 338 6827568  ·  a.lotti@kedrion.com

Linda Karpiak  ·  973-216-0484  ·  l.karpiak@kedrion.com

Always discuss trial participation with your own doctor first.

Locations (28)

University of Southern CaliforniaLos Angeles, California, United StatesRecruiting
NY Cancer and Blood SpecialistsShirley, New York, United StatesRecruiting
East Carolina UniversityGreenville, North Carolina, United StatesRecruiting
Vseobecna Fakultni Nemocnice v PrazePrague, Prague, CzechiaRecruiting
Fakultni Nemocnice BrnoBrno, South Moravian, CzechiaRecruiting
Onkologisches Zentrum Donauwörth Neudegger - Onkomedeor Onkologische ZentrenDonauwörth, Bavaria, GermanyWithdrawn
Universitätsklinikum FrankfurtFrankfurt am Main, Hesse, GermanyRecruiting
Azienda Ospedaliero - Universitaria CareggiFlorence, Florence, ItalyRecruiting
Azienda Ospedaliero-Universitaria Maggiore della Carità di NovaraNovara, Novara, ItalyRecruiting
Azienda Sanitaria Universitaria Giuliano IsontinaTrieste, Trieste, ItalyRecruiting
Azienda Ospedaliero-Universitaria Citta della Salute e della Scienza di TorinoTorino, Turin, ItalyRecruiting
AULSS 8 Berica - Ospedale San Bortolo Di VicenzaVicenza, Vicenza, ItalyRecruiting

+ 16 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07059000